Benefits of Adjuvant Mitotane after Resection of Adrenocortical Carcinoma: A Systematic Review and Meta-Analysis

BACKGROUND: The adjuvant use of mitotane on adrenocortical carcinoma (ACC) has always been in controversy. We aimed to assess the prognostic benefits of adjuvant mitotane after resection of ACC in patients without distant metastasis. METHODS: The PubMed, WoS, Embase, and Cochrane Library databases w...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Biomed Res Int
Asıl Yazarlar: Tang, Yongquan, Liu, Zhihong, Zou, Zijun, Liang, Jiayu, Lu, Yiping, Zhu, Yuchun
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Hindawi 2018
Konular:
Review Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6008618/
https://ncbi.nlm.nih.gov/pubmed/29967789
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/9362108
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller